Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cognitive Performance on Treadmill with Methylphenidate in ADHD
NCT05243186Phase 3Unknown
- Sponsor
- Ariel University
- Start
- Oct 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Ariel University. Status: unknown.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT05243186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05243186.